Decreased CD127 expression on CD4+ T-cells and elevated frequencies of cd4+cd25+cd127-T-cells in children with long-lasting type 1 diabetes

Clinical and Developmental Immunology

Volumn 2013, Issue , 2013, Pages

  Moniuszko, Marcin ^a   Glowinska Olszewska, Barbara ^a   Rusak, Malgorzata ^a   Jeznach, Marta ^a   Grubczak, Kamil ^a   Lipinska, Danuta ^a   Milewski, Robert ^a   Milewska, Anna Justyna ^a   Dabrowska, Milena ^a   Jablonska, Ewa ^a   Kretowski, Adam ^a   Gorska, Maria ^a   Bodzenta Lukaszyk, Anna ^a   Bossowski, Artur ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN; CD34 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 7 RECEPTOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR ALPHA;

ADOLESCENT; ADULT; ANTIGEN EXPRESSION; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; LEUKOCYTE COUNT; MALE; PHENOTYPE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SCHOOL CHILD; CASE CONTROL STUDY; CD4+ T LYMPHOCYTE; IMMUNOLOGY; IMMUNOPHENOTYPING; LYMPHOCYTE COUNT; METABOLISM; RISK FACTOR;

ADOLESCENT; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHILD; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-7 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE COUNT; MALE; PHENOTYPE; RISK FACTORS;

EID: 84890052803     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2013/459210     Document Type: Article

References (52)

1. Cnop M., Welsh N., Jonas J. C., Jorns A., Lenzen S., Eizirik D. L., Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes 2005 54 2 S97 S107 2-s2.0-33644749322 10.2337/diabetes.54.suppl-2.S97 (Pubitemid 43343337)
2. Faideau B., Larger E., Lepault F., Carel J. C., Boitard C., Role of beta-cells in type 1 diabetes pathogenesis. Diabetes 2005 54 2 S87 S96 2-s2.0-33644773598 10.2337/diabetes.54.suppl-2.S87 (Pubitemid 43343336)
3. Schluns K. S., Kieper W. C., Jameson S. C., Lefrançois L., Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nature Immunology 2000 1 5 426 432 2-s2.0-0034332403
4. Chetoui N., Boisvert M., Gendron S., Aoudjit F., Interleukin-7 promotes the survival of human CD4+ effector/memory T cells by up-regulating Bcl-2 proteins and activating the JAK/STAT signalling pathway. Immunology 2010 130 3 418 426 2-s2.0-77953481128 10.1111/j.1365-2567.2009.03244.x
5. Fry T. J., Mackall C. L., The many faces of IL-7: from lymphopoiesis to peripheral T cell maintenance. Journal of Immunology 2005 174 11 6571 6576 2-s2.0-18944379196 (Pubitemid 40705615)
6. Koesters S. A., Alimonti J. B., Wachihi C., Matu L., Anzala O., Kimani J., Embree J. E., Plummer F. A., Fowke K. R., IL-7R alpha expression on CD4+ T lymphocytes decreases with HIV disease progression and inversely correlates with immune activation. European Journal of Immunology 2006 36 2 336 344 2-s2.0-32944455546 10.1002/eji.200535111 (Pubitemid 43257456)
7. Hartigan-O'Connor D. J., Poon C., Sinclair E., McCune J. M., Human CD4+ regulatory T cells express lower levels of the IL-7 receptor alpha chain (CD127), allowing consistent identification and sorting of live cells. Journal of Immunological Methods 2007 319 1-2 41 52 2-s2.0-33846283803 10.1016/j.jim.2006.10.008 (Pubitemid 46110995)
8. Sakaguchi S., Miyara M., Costantino C. M., Hafler D. A., FOXP3 + regulatory T cells in the human immune system. Nature Reviews Immunology 2010 10 7 490 500 2-s2.0-77954141914 10.1038/nri2785
9. Kukreja A., Cost G., Marker J., Zhang C., Sun Z., Lin-Su K., Ten S., Sanz M., Exley M., Wilson B., Porcelli S., Maclaren N., Multiple immuno-regulatory defects in type-1 diabetes. Journal of Clinical Investigation 2002 109 1 131 140 2-s2.0-0036141438 10.1172/JCI200213605 (Pubitemid 34052549)
10. Luczynski W., Wawrusiewicz-Kurylonek N., Stasiak-Barmuta A., Urban R., Iłendo E., Urban M., Hryszko M., Kretowski A., Górska M., Diminished expression of ICOS, GITR and CTLA-4 at the mRNA level in T regulatory cells of children with newly diagnosed type 1 diabetes. Acta Biochimica Polonica 2009 56 2 361 370 2-s2.0-68249100526
11. Ryba M., Marek N., Hak L., Rybarczyk-Kapturska K., Myśliwiec M., Trzonkowski P., Myśliwska J., Anti-TNF rescue CD4(+)Foxp3(+) regulatory T cells in patients with type 1 diabetes from effects mediated by TNF. Cytokine 2011 55 3 353 361 2-s2.0-79960893564 10.1016/j.cyto.2011.05.006
12. Ryba M., Hak L., Zorena K., Myoeliwiec M., Myoeliwska J., CD4+Foxp3+ regulatory T lymphocytes expressing CD62L in patients with long-standing diabetes type 1. Central-European Journal of Immunology 2009 34 2 90 93 2-s2.0-70349619401
13. Marek-Trzonkowska N., Mysliwiec M., Dobyszuk A., Administration of CD4+CD25highCD127(-) regulatory T cells preserves beta-cell function in type 1 diabetes in children. Diabetes Care 2012 35 1817 1820
14. Crawley A. M., Angel J. B., The influence of HIV on CD127 expression and its potential implications for IL-7 therapy. Seminars in Immunology 2012 24 231 240 2-s2.0-84857937063 10.1016/j.smim.2012.02.006
15. Moniuszko M., Edghill-Smith Y., Venzon D., Stevceva L., Nacsa J., Tryniszewska E., Tsai W.-P., Franchini G., Decreased number of CD4+ and CD8+ T cells that express the interleukin-7 receptor in blood and tissues of SIV-infected macaques. Virology 2006 356 1-2 188 197 2-s2.0-33750990205 10.1016/j.virol.2006.07.031 (Pubitemid 44750035)
16. Faller E. M., Sugden S. M., McVey M. J., Kakal J. A., MacPherson P. A., Soluble HIV Tat protein removes the IL-7 receptor alpha-chain from the surface of resting CD8 T cells and targets it for degradation. Journal of Immunology 2010 185 5 2854 2866 2-s2.0-78049385847 10.4049/jimmunol.0902207
17. Kiazyk S. A. K., Fowke K. R., Loss of CD127 expression links immune activation and CD4+ T cell loss in HIV infection. Trends in Microbiology 2008 16 12 567 573 2-s2.0-56649124632 10.1016/j.tim.2008.08.011
18. Nemes E., Lugli E., Nasi M., Ferraresi R., Pinti M., Bugarini R., Borghi V., Prati F., Esposito R., Cossarizza A., Mussini C., Immunophenotype of HIV+ patients during CD4 cell-monitored treatment interruption: role of the IL-7/IL-7 receptor system. AIDS 2006 20 16 2021 2032 2-s2.0-33750277044 10.1097/01.aids.0000247575.41622.b1 (Pubitemid 44611055)
19. Rethi B., Fluur C., Atlas A., Krzyzowska M., Mowafi F., Grützmeier S., De Milito A., Bellocco R., Falk K. I., Rajnavölgyi E., Chiodi F., Loss of IL-7R alpha is associated with CD4 T-cell depletion, high interleukin-7 levels and CD28 down-regulation in HIV infected patients. AIDS 2005 19 18 2077 2086 2-s2.0-27944503411 (Pubitemid 41668995)
20. Moniuszko M., Kowal K., Jeznach M., Phenotypic correlations between monocytes and CD4+ T cells in allergic patients. International Archives of Allergy and Immunology 2013 161 131 141
21. Aerts N. E., Dombrecht E. J., Ebo D. G., Bridts C. H., Stevens W. J., De Clerck L. S., Activated T cells complicate the identification of regulatory T cells in rheumatoid arthritis. Cellular Immunology 2008 251 2 109 115 2-s2.0-48949115607 10.1016/j.cellimm.2008.04.008
22. Hartgring S. A. Y., Willis C. R., Alcorn D., Nelson L. J., Bijlsma J. W. J., Lafeber F. P. J. G., Van Roon J. A. G., Blockade of the interleukin-7 receptor inhibits collagen-induced arthritis and is associated with reduction of T cell activity and proinflammatory mediators. Arthritis and Rheumatism 2010 62 9 2716 2725 2-s2.0-77956380527 10.1002/art.27578
23. Penaranda C., Kuswanto W., Hofmann J., IL-7 receptor blockade reverses autoimmune diabetes by promoting inhibition of effector/memory T cells. Proceedings of the National Academy of Sciences of the United States of America 2012 109 12668 12673
24. Lee L. F., Logronio K., Tu G. H., Anti-IL-7 receptor-alpha reverses established type 1 diabetes in nonobese diabetic mice by modulating effector T-cell function. Proceedings of the National Academy of Sciences of the United States of America 2012 109 12674 12679
25. Nilsson J., Hansson G. K., Autoimmunity in atherosclerosis: a protective response losing control? Journal of Internal Medicine 2008 263 5 464 478 2-s2.0-42149190800 10.1111/j.1365-2796.2008.01945.x (Pubitemid 351533555)
26. Blasi C., The autoimmune origin of atherosclerosis. Atherosclerosis 2008 201 1 17 32 2-s2.0-53849105417 10.1016/j.atherosclerosis.2008.05.025
27. Nilsson J., Bengtsson E., Fredrikson G. N., Björkbacka H., Inflammation and immunity in diabetic vascular complications. Current Opinion in Lipidology 2008 19 5 519 524 2-s2.0-53549101280 10.1097/MOL.0b013e32830f47cd
28. Triolo T. M., Armstrong T. K., McFann K., Yu L., Rewers M. J., Klingensmith G. J., Eisenbarth G. S., Barker J. M., Additional autoimmune disease found in 33% of patients at type 1 diabetes onset. Diabetes Care 2011 34 5 1211 1213 2-s2.0-79956081185 10.2337/dc10-1756
29. Warncke K., Fröhlich-Reiterer E. E., Thon A., Hofer S. E., Wiemann D., Holl R. W., Polyendocrinopathy in children, adolescents, and young adults with type 1 diabetes: a multicenter analysis of 28,671 patients from the German/Austrian DPV-Wiss database. Diabetes Care 2010 33 9 2010 2012 2-s2.0-79951635809 10.2337/dc10-0404
30. Glowinska-Olszewska B., Moniuszko M., Hryniewicz A., Relationship between circulating endothelial progenitor cells and endothelial dysfunction in children with type 1 diabetes: a novel paradigm of early atherosclerosis in high-risk young patients. European Journal of Endocrinology 2013 168 153 161
31. Corretti M. C., Anderson T. J., Benjamin E. J., International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. Journal of the American College of Cardiology 2002 39 257 265 (Pubitemid 34084631)
32. Mallone R., Van Endert P., T cells in the pathogenesis of type 1 diabetes. Current Diabetes Reports 2008 8 2 101 106 2-s2.0-44849112223 10.1007/s11892-008-0019-9
33. Hedman M., Faresjo M., Axelsson S., Ludvigsson J., Casas R., Impaired CD4(+) and CD8(+) T cell phenotype and reduced chemokine secretion in recent-onset type 1 diabetic children. Clinical and Experimental Immunology 2008 152 3 360 368 2-s2.0-49649098179 10.1111/j.1365-2249.2008.03720.x
34. Lindley S., Dayan C. M., Bishop A., Roep B. O., Peatman M., Tree T. I. M., Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes. Diabetes 2005 54 1 92 99 2-s2.0-12144249838 10.2337/diabetes.54.1.92 (Pubitemid 40105099)
35. Viglietta V., Baecher-Allan C., Weiner H. L., Hafler D. A., Loss of functional suppression by CD4(+)CD25(+) regulatory T-cells in patients with multiple sclerosis. Journal of Experimental Medicine 2004 199 7 971 979 2-s2.0-1842732224 10.1084/jem.20031579 (Pubitemid 38481088)
36. Holmen N., Lundgren A., Lundin S., Bergin A. M., Rudin A., Sjovall H., Ohman L., Functional CD4(+)CD25(high) regulatory T cells are enriched in the colonic mucosa of patients with active ulcerative colitis and increase with disease activity. Inflammatory Bowel Diseases 2006 12 6 447 456 2-s2.0-33745275219 10.1097/00054725-200606000-00003
37. Taflin C., Miyara M., Nochy D., Valeyre D., Naccache J. M., Altare F., Salek-Peyron P., Badoual C., Bruneval P., Haroche J., Mathian A., Amoura Z., Hill G., Gorochov G., FoxP3(+) regulatory T cells suppress early stages of granuloma formation but have little impact on sarcoidosis lesions. American Journal of Pathology 2009 174 2 497 508 2-s2.0-59649099784 10.2353/ajpath.2009. 080580
38. Ryba-Stanisławowska M., Skrzypkowska M., Myśliwiec M., Loss of the balance between CD4(+)Foxp3(+) regulatory T cells and CD4(+)IL17A(+) Th17 cells in patients with type 1 diabetes. Human Immunology 2013 74 701 707
39. Zeng C., Shi X., Zhang B., Liu H., Zhang L., Ding W., Zhao Y., The imbalance of Th17/Th1/Tregs in patients with type 2 diabetes: relationship with metabolic factors and complications. Journal of Molecular Medicine 2012 90 2 175 186 2-s2.0-84857371931 10.1007/s00109-011-0816-5
40. Schwartzenberg S., Mor A., Luboshits G., Association between circulating early endothelial progenitors and CD4+CD25+ regulatory T cells: a possible cross-talk between immunity and angiogenesis? American Journal of Immunology 2005 1 143 147
41. Zimmerman M. A., Flores S. C., Autoimmune-mediated oxidative stress and endothelial dysfunction: implications of accelerated vascular injury in type I diabetes. Journal of Surgical Research 2009 155 1 173 178 2-s2.0-67349165853 10.1016/j.jss.2008.04.026
42. Pan X. J., Yuan X. L., Zheng Y. X., Wang W., Shan J., Lin F., Jiang G., Yang Y. H., Wang D., Xu D., Shen L., Increased CD45RA+FOXP3low regulatory T cells with impaired suppressive function in patients with systemic lupus erythematosus. Plos ONE 2012 7 4 2-s2.0-84859577191 10.1371/journal.pone.0034662 e34662
43. Cao D., van Vollenhoven R., Klareskog L., Trollmo C., Malmström V., CD25(bright)CD4(+) regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease. Arthritis Research and Therapy 2004 6 4 R335 346 2-s2.0-15244361536
44. Alvarado-Sanchez B., Hernandez-Castro B., Portales-Perez D., Regulatory T cells in patients with systemic lupus erythematosus. Journal of Autoimmunity 2006 27 110 118 (Pubitemid 44528260)
45. Brusko T., Wasserfall C., McGrail K., Schatz R., Viener H. L., Schatz D., Haller M., Rockell J., Gottlieb P., Clare-Salzler M., Atkinson M., No alterations in the frequency of FOXP3(+) regulatory T-cells in type 1 diabetes. Diabetes 2007 56 3 604 612 2-s2.0-33847373481 10.2337/db06-1248 (Pubitemid 46348451)
46. Nilsson J., Wigren M., Shah P. K., Regulatory T cells and the control of modified lipoprotein autoimmunity-driven atherosclerosis. Trends in Cardiovascular Medicine 2009 19 8 272 276 2-s2.0-77952527041 10.1016/j.tcm.2010.02.010
47. Nilsson J., Fredrikson G. N., Björkbacka H., Chyu K.-Y., Shah P. K., Vaccines modulating lipoprotein autoimmunity as a possible future therapy for cardiovascular disease. Journal of Internal Medicine 2009 266 3 221 231 2-s2.0-68949118039 10.1111/j.1365-2796.2009.02150.x
48. Yang J. B., Danke N., Roti M., Huston L., Greenbaum C., Pihoker C., James E., Kwok W. W., CD4+ T cells from type 1 diabetic and healthy subjects exhibit different thresholds of activation to a naturally processed proinsulin epitope. Journal of Autoimmunity 2008 31 1 30 41 2-s2.0-43649105125 10.1016/j.jaut.2008. 02.001
49. Aarnisalo J., Treszl A., Svec P., Marttila J., Öling V., Simell O., Knip M., Körner A., Madacsy L., Vasarhelyi B., Ilonen J., Hermann R., Reduced CD4(+)T cell activation in children with type 1 diabetes carrying the PTPN22/Lyp 620Trp variant. Journal of Autoimmunity 2008 31 1 13 21 2-s2.0-43849091645 10.1016/j.jaut.2008.01.001
50. Baker C., Chang L., Elsegood K. A., Bishop A. J., Gannon D. H., Narendran P., Leech N. J., Dayan C. M., Activated T cell subsets in human type 1 diabetes: evidence for expansion of the DR+ CD30(+) subpopulation in new-onset disease. Clinical and Experimental Immunology 2007 147 3 472 482 2-s2.0-33846807498 10.1111/j.1365-2249.2006.03307.x (Pubitemid 46208048)
51. Ming J., Zhang Q., Qiu X., Wang E., Interleukin 7/interleukin 7 receptor induce c-Fos/c-Jun-dependent vascular endothelial growth factor-D up-regulation: a mechanism of lymphangiogenesis in lung cancer. European Journal of Cancer 2009 45 5 866 873 2-s2.0-61349123540 10.1016/j.ejca.2008.12.006
52. Yadav A. K., Lal A., Jha V., Association of circulating fractalkine (CX3CL1) and CX3CR1(+)CD4(+) T cells with common carotid artery intima-media thickness in patients with chronic kidney disease. Journal of Atherosclerosis and Thrombosis 2011 18 11 958 965 2-s2.0-82455164442